Investing Profile

Patrick Heron

InvestorVC

Managing Partner at Frazier Healthcare Partners

frazierhealthcare.com/team/pa...Menlo Park, California
Photo of Patrick Heron, Managing Partner at Frazier Healthcare Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
13
CompanyStageDateRound SizeTotal Raised
SanReno Therapeutics
Funding RoundNov 2021$40M
$40M
MBX Biosciences
Series AJul 2020$35M
$35M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Carl Gordon (OrbiMed)
Passage Bio
Series BSep 2019$110M
Series AFeb 2019$120M
$230M
Co-investors: Carl Gordon (OrbiMed), Liam Ratcliffe (Access Biotechnology)
Recida Therapeutics
Series AFeb 2019$8.5M
$8.5M
Mirum Pharmaceuticals
Series ANov 2018$120M
$120M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Niall O’Donnell (RiverVest), Jonathan Leff (Deerfield Management)
Zavante Therapeutics
Series AMar 2016$45M
$45M
Co-investors: Andrew Schiff (Aisling Capital)
VentiRx Pharmaceuticals
Series BSep 2014$51M
Series AJan 2010$25M
Series AMar 2007$27M
$100M
Co-investors: Steven Gillis (ARCH Venture Partners), Nicole Vitullo (Domain Associates)
Collegium Pharmaceutical
Venture RoundFeb 2012$23M
$23M